Hepatic porphyria: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Hepatic porphyria | |||
| synonyms = | |||
| field = [[Hepatology]], [[Genetics]] | |||
| symptoms = Abdominal pain, vomiting, neuropathy, mental disturbances | |||
| complications = [[Liver damage]], [[Kidney failure]] | |||
| onset = Typically in adulthood | |||
| duration = Chronic | |||
| causes = Genetic mutations affecting [[heme]] biosynthesis | |||
| risks = [[Alcohol consumption]], certain medications, [[hormonal changes]] | |||
| diagnosis = [[Urine test]], [[Blood test]], [[Genetic testing]] | |||
| differential = [[Acute intermittent porphyria]], [[Lead poisoning]], [[Guillain–Barré syndrome]] | |||
| treatment = [[Intravenous glucose]], [[Hemin]], [[Pain management]] | |||
| medication = [[Hemin]], [[Beta blockers]] | |||
| frequency = Rare | |||
| deaths = Can be fatal if untreated | |||
}} | |||
'''Hepatic porphyria''' is a group of rare, genetic disorders characterized by problems in the production of heme, a vital component of hemoglobin, the protein in red blood cells that binds and carries oxygen. These disorders are termed "hepatic" because the liver is the primary site of the disturbance in heme production. Porphyrias are classified based on where the production of heme is disrupted: in the liver (hepatic) or in the bone marrow (erythropoietic). Hepatic porphyrias lead to the accumulation of porphyrins or porphyrin precursors, substances that are normally intermediates in the production of heme, causing a variety of symptoms. | '''Hepatic porphyria''' is a group of rare, genetic disorders characterized by problems in the production of heme, a vital component of hemoglobin, the protein in red blood cells that binds and carries oxygen. These disorders are termed "hepatic" because the liver is the primary site of the disturbance in heme production. Porphyrias are classified based on where the production of heme is disrupted: in the liver (hepatic) or in the bone marrow (erythropoietic). Hepatic porphyrias lead to the accumulation of porphyrins or porphyrin precursors, substances that are normally intermediates in the production of heme, causing a variety of symptoms. | ||
==Types of Hepatic Porphyria== | ==Types of Hepatic Porphyria== | ||
There are several types of hepatic porphyria, each with its own specific symptoms and genetic causes. The most common types include: | There are several types of hepatic porphyria, each with its own specific symptoms and genetic causes. The most common types include: | ||
* [[Acute Intermittent Porphyria (AIP)]] | * [[Acute Intermittent Porphyria (AIP)]] | ||
* [[Porphyria Cutanea Tarda (PCT)]] | * [[Porphyria Cutanea Tarda (PCT)]] | ||
* [[Hereditary Coproporphyria (HCP)]] | * [[Hereditary Coproporphyria (HCP)]] | ||
* [[Variegate Porphyria (VP)]] | * [[Variegate Porphyria (VP)]] | ||
==Symptoms== | ==Symptoms== | ||
Symptoms of hepatic porphyria can vary widely among individuals and between the different types of porphyrias. They can be categorized into two main groups: acute (neurovisceral) symptoms and cutaneous (skin) symptoms. | Symptoms of hepatic porphyria can vary widely among individuals and between the different types of porphyrias. They can be categorized into two main groups: acute (neurovisceral) symptoms and cutaneous (skin) symptoms. | ||
===Acute Symptoms=== | ===Acute Symptoms=== | ||
Acute symptoms are primarily neurological and can be severe. They include: | Acute symptoms are primarily neurological and can be severe. They include: | ||
| Line 19: | Line 33: | ||
* Seizures | * Seizures | ||
* Muscle weakness or paralysis | * Muscle weakness or paralysis | ||
===Cutaneous Symptoms=== | ===Cutaneous Symptoms=== | ||
Cutaneous symptoms occur due to the skin's sensitivity to sunlight and can include: | Cutaneous symptoms occur due to the skin's sensitivity to sunlight and can include: | ||
| Line 27: | Line 40: | ||
* Increased hair growth on the affected area | * Increased hair growth on the affected area | ||
* Scarring | * Scarring | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of hepatic porphyria involves a combination of clinical evaluation, family history, and specialized laboratory tests that measure porphyrins and their precursors in blood, urine, and stool. | Diagnosis of hepatic porphyria involves a combination of clinical evaluation, family history, and specialized laboratory tests that measure porphyrins and their precursors in blood, urine, and stool. | ||
==Treatment== | ==Treatment== | ||
Treatment for hepatic porphyria focuses on managing symptoms and preventing acute attacks. This may include: | Treatment for hepatic porphyria focuses on managing symptoms and preventing acute attacks. This may include: | ||
| Line 36: | Line 47: | ||
* Treatment with heme arginate or hemin for acute attacks | * Treatment with heme arginate or hemin for acute attacks | ||
* Phlebotomy or low-dose chloroquine for PCT to reduce iron and porphyrin levels | * Phlebotomy or low-dose chloroquine for PCT to reduce iron and porphyrin levels | ||
==Genetics== | ==Genetics== | ||
Hepatic porphyrias are inherited in an autosomal dominant manner, meaning a mutation in just one of the two copies of the gene is sufficient to increase the risk of developing the disorder. However, not all individuals with a mutation will experience symptoms, a phenomenon known as incomplete penetrance. | Hepatic porphyrias are inherited in an autosomal dominant manner, meaning a mutation in just one of the two copies of the gene is sufficient to increase the risk of developing the disorder. However, not all individuals with a mutation will experience symptoms, a phenomenon known as incomplete penetrance. | ||
==Prevention== | ==Prevention== | ||
Preventive measures for those with hepatic porphyria or at risk include avoiding known triggers, regular monitoring for symptoms, and genetic counseling for affected families. | Preventive measures for those with hepatic porphyria or at risk include avoiding known triggers, regular monitoring for symptoms, and genetic counseling for affected families. | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Liver diseases]] | [[Category:Liver diseases]] | ||
[[Category:Metabolic disorders]] | [[Category:Metabolic disorders]] | ||
{{Medicine-stub}} | {{Medicine-stub}} | ||
Latest revision as of 01:39, 4 April 2025
| Hepatic porphyria | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Abdominal pain, vomiting, neuropathy, mental disturbances |
| Complications | Liver damage, Kidney failure |
| Onset | Typically in adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutations affecting heme biosynthesis |
| Risks | Alcohol consumption, certain medications, hormonal changes |
| Diagnosis | Urine test, Blood test, Genetic testing |
| Differential diagnosis | Acute intermittent porphyria, Lead poisoning, Guillain–Barré syndrome |
| Prevention | N/A |
| Treatment | Intravenous glucose, Hemin, Pain management |
| Medication | Hemin, Beta blockers |
| Prognosis | N/A |
| Frequency | Rare |
| Deaths | Can be fatal if untreated |
Hepatic porphyria is a group of rare, genetic disorders characterized by problems in the production of heme, a vital component of hemoglobin, the protein in red blood cells that binds and carries oxygen. These disorders are termed "hepatic" because the liver is the primary site of the disturbance in heme production. Porphyrias are classified based on where the production of heme is disrupted: in the liver (hepatic) or in the bone marrow (erythropoietic). Hepatic porphyrias lead to the accumulation of porphyrins or porphyrin precursors, substances that are normally intermediates in the production of heme, causing a variety of symptoms.
Types of Hepatic Porphyria[edit]
There are several types of hepatic porphyria, each with its own specific symptoms and genetic causes. The most common types include:
- Acute Intermittent Porphyria (AIP)
- Porphyria Cutanea Tarda (PCT)
- Hereditary Coproporphyria (HCP)
- Variegate Porphyria (VP)
Symptoms[edit]
Symptoms of hepatic porphyria can vary widely among individuals and between the different types of porphyrias. They can be categorized into two main groups: acute (neurovisceral) symptoms and cutaneous (skin) symptoms.
Acute Symptoms[edit]
Acute symptoms are primarily neurological and can be severe. They include:
- Abdominal pain
- Vomiting
- Neuropsychiatric symptoms, such as anxiety, confusion, hallucinations, or depression
- Seizures
- Muscle weakness or paralysis
Cutaneous Symptoms[edit]
Cutaneous symptoms occur due to the skin's sensitivity to sunlight and can include:
- Blisters
- Itching
- Swelling
- Increased hair growth on the affected area
- Scarring
Diagnosis[edit]
Diagnosis of hepatic porphyria involves a combination of clinical evaluation, family history, and specialized laboratory tests that measure porphyrins and their precursors in blood, urine, and stool.
Treatment[edit]
Treatment for hepatic porphyria focuses on managing symptoms and preventing acute attacks. This may include:
- Avoiding triggers such as certain drugs, alcohol, and fasting
- Treatment with heme arginate or hemin for acute attacks
- Phlebotomy or low-dose chloroquine for PCT to reduce iron and porphyrin levels
Genetics[edit]
Hepatic porphyrias are inherited in an autosomal dominant manner, meaning a mutation in just one of the two copies of the gene is sufficient to increase the risk of developing the disorder. However, not all individuals with a mutation will experience symptoms, a phenomenon known as incomplete penetrance.
Prevention[edit]
Preventive measures for those with hepatic porphyria or at risk include avoiding known triggers, regular monitoring for symptoms, and genetic counseling for affected families.
